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RESEARCH ARTICLE Open Access
Does preoperative dipyridamole-thallium
scanning reduce 90-day cardiac
complications and 1-year mortality in
patients with femoral neck fractures
undergoing hemiarthroplasty?
Chin-Yi Liao1, Timothy L. Tan2, Yu-Der Lu1, Cheng-Ta Wu1, Mel S. Lee1 and Feng-Chih Kuo1*
Abstract
Background: This study aimed to evaluate the effect of dipyridamole-thallium scanning (DTS) on the rates of 90-
day cardiac complications and 1-year mortality in patients with a femoral neck fracture treated with
hemiarthroplasty.
Methods: Between 2008 and 2015, 844 consecutive patients who underwent cemented or cementless
hemiarthroplasty were identified from the database of a single level-one medical center. One-hundred and thirteen
patients (13%) underwent DTS prior to surgery, and 731 patients (87%) did not. Patient characteristics,
comorbidities, surgical variables, and length of the delay until surgery were recorded. A propensity score-matched
cohort was utilized to reduce recruitment bias in a 1:3 ratio of DTS group to control group, and multivariate logistic
regression was performed to control confounding variables.
Results: The incidence of 90-day cardiac complications was 19.5% in the DTS group and 15.6% in the control
group (p = 0.343) among 452 patients after propensity score-matching. The 1-year mortality rate (10.6% vs 13.3%, p
= 0.462) was similar in the two groups. In the propensity score-matched patients, utilization of DTS was not
associated with a reduction in the rate of 90-day cardiac complications (matched cohort, adjusted odds ratio [aOR]
= 1.32; 95% confidence interval [CI] 0.75–2.33, p = 0.332) or the 1-year mortality rate (aOR = 0.62; 95% CI 0.27–1.42,
p = 0.259). Risk factors for cardiac complications included an American Society of Anesthesiologists grade ≥ 3 (OR
3.19, 95% CI 1.44–7.08, p = 0.004) and pre-existing cardiac comorbidities (OR 5.56, 95% CI 3.35–9.25, p < 0.001). Risk
factors for 1-year mortality were a long time to surgery (aOR 1.15, 95% CI 1.06–1.25, p = 0.001), a greater age (aOR
1.05, 95% CI 1.00 to 1.10, p = 0.040), a low body mass index (BMI; aOR 0.89, 95% CI 0.81–0.98, p = 0.015), and the
presence of renal disease (aOR 4.43, 95% CI 1.71–11.46, p = 0.002).
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Discussion: Preoperative DTS was not associated with reductions in the rates of 90-day cardiac complications or 1-
year mortality in patients with a femoral neck fracture undergoing hemiarthroplasty. The necessity for DTS should
be re-evaluated in elderly patients with femoral neck fractures, given that this increases the length of the delay until
surgery.
Level of evidence: Prognostic level III
Keywords: Dipyridamole-thallium scanning, Femoral neck fracture, Mortality, Cardiac complications,
Hemiarthroplasty
Introduction
Femoral neck fracture is a geriatric low-energy trauma
with an increasing incidence in Asia [1] and has pro-
found economic and medical impacts worldwide [2, 3].
The standard treatment for displaced femoral neck frac-
tures in geriatric patients is arthroplasty [4]; however,
patients may experience significant morbidity and mor-
tality due to pre-existing cardiovascular comorbidities
and insult from surgery [5]. Therefore, it is common
practice to hold a preoperative consultation with internal
medicine doctors or anesthesiologists for risk stratifica-
tion and treatment optimization.
Dipyridamole-thallium scanning (DTS), or 201-
scintigraphy, has been suggested as a method of preopera-
tively assessing cardiac risk in patients undergoing major
non-cardiac surgery. The American College of Cardiology
(ACC) and American Heart Association (AHA) guidelines
include DTS as one of the modalities for perioperative
cardiovascular evaluation prior to non-cardiac surgery [6,
7]. In terms of preoperative practice in other specialties,
for instance, Landesberg et al. [8] examined the use of
thallium scanning and selective coronary angiography
prior to major vascular therapy and reported a significant
improvement in the long-term outcome. Yin et al. [9] also
demonstrated that applying preoperative DTS can prevent
cardiac mortality and complications in patients undergo-
ing parathyroidectomy. Hemiarthroplasty is classified as
intermediate cardiac risk procedure, with reported peri-
operative morbidity rates ranging from 1 to 5% according
to the ACC/AHA preoperative guidelines [6]. However,
there is minimal literature on whether this examination
results in any differences in outcomes in patients undergo-
ing surgery for the treatment of a hip fracture.
The purpose of this study was to evaluate the correla-
tions of DTS with the rates of 90-day cardiac complica-
tions and 1-year mortality in patients with a femoral
neck fracture treated with hemiarthroplasty. We hypoth-
esized that if DTS reduces the risk of postoperative com-
plications, or if further selective preoperative treatment
such as coronary intervention may be indicated in light
of the results of DTS, the rate of postoperative cardiac
complications may be reduced by balancing the bias in
these patients.
Materials and methods
Data source and patients
The Institutional Review Board (IRB) approved the study
protocol, and patient consent was waived by the IRB, as
all personal identifying information was removed from
the dataset and strict anonymity was maintained before
further analysis. The duration of IRB approval was from
August 2016 to October 2016, and privacy regulations
related to the research database in our institution were
adhered to in order to prevent confidential information
being utilized against medical ethics. We retrospectively
enrolled 968 consecutive patients undergoing hemiar-
throplasty whose data were obtained from a trauma
database held at a single academic institution from Janu-
ary 2008 to December 2015. Raw data acquisition was
completed in 2months; however, data completeness, re-
liability, organization details, and patient exclusions were
manually reviewed by 3 independent authors (CYL,
YDL, and CTW) to prevent observation bias. The inclu-
sion criteria were patients with displaced femoral neck
fractures who were older than 60 years. Patients with a
non-displaced fracture, those aged under 60 years, and
those with multiple trauma, valgus impacted fracture,
pathologic fracture, or open fracture were excluded.
After application of the exclusion criteria, 844 patients
with displaced femoral neck fractures who underwent
cemented or cementless hemiarthroplasty were included
in this study.
All patients underwent a preoperative medical examin-
ation that included a resting electrocardiogram, chest
radiography and blood test. Following this screening,
they were seen by an anesthesiologist before surgery,
and a cardiology consultation was obtained if concerns
were raised by the anesthesiologist. The cardiologist or
physician evaluated the patients undergoing non-cardiac
surgery based on the 2007 ACC/AHA guidelines on
perioperative cardiovascular evaluation [6]. As per the
guidelines, routine screening with non-invasive stress
testing was not performed in patients undergoing low-
risk non-cardiac surgery; however, if the test results im-
pacted on our decision-making, including canceling the
operation or changing the perioperative care, this testing
was arranged for patients with an elevated cardiac risk
Liao et al. Journal of Orthopaedic Surgery and Research          (2020) 15:385 Page 2 of 10
and a poor metabolic equivalent of task (MET < 4). If
the patient had an elevated cardiac risk but a functional
capacity greater than or equal to a MET of 4 without
symptoms, the planned surgery would proceed.
Patients were divided into two categories based on re-
ceipt of DTS. The control group included patients who
underwent surgery without DTS after consultation with
an anesthesiologist or cardiologist, while the study group
included patients who underwent DTS. Patients with ab-
normal scan results were further evaluated by a cardiolo-
gist with regard to coronary angiography intervention.
Indications for coronary angiography were based on
clinical findings, such as new or medically unstable an-
gina, previous or recent myocardial infarction, or persist-
ent angina. Stent implantation or balloon angioplasty
during angiography was performed if coronary arterial
stenosis was greater than 50%, multiple-vessel disease
was present, or left main coronary artery occlusion was
observed.
Variables of interest were extracted by electronic query
of medical records and reviewed manually. The follow-
ing information was obtained: basic demographic data,
age, gender, body mass index (BMI), American Society
of Anesthesiologists (ASA) grade, and preoperative co-
morbidities, including ischemic heart disease, congestive
heart failure, valvular heart disease, cerebrovascular acci-
dent (CVA), diabetes, chronic obstructive pulmonary
disease (COPD), rheumatoid arthritis, liver disease, renal
disease, and a history of cancer (Table 1). In addition,
the duration from hospital presentation to surgery,
anesthesia type (regional or general), use of cemented or
cementless fixation, duration of surgery, and need for
transfusion were also obtained.
Surgical techniques
All hemiarthroplasty surgeries were performed through
the posterolateral approach in a lateral decubitus pos-
ition. All patients were treated using a cemented or
cementless fixation technique by well-trained orthopedic
surgeons. The cemented or press-fit implants were
chosen based on preoperative imaging evaluation for
osteoporosis and intraoperative trial implantation at the
discretion of the treating surgeons. Intraoperative joint
capsules were approximated by sutures, and a closed
drainage tube was inserted, which was removed within
24–48 h. A partial weight-bearing rehabilitation program
was initiated by a physical therapist from postoperative
day 1. If a patient was unable to ambulate using a
walker, wheelchair ambulation was recommended.
Outcome measurement
The outcomes of this study included the rates of postop-
erative 90-day cardiac complications, 90-day mortality,
and 1-year mortality after the index hemiarthroplasty.
ICD-9 codes were used to identify 90-day cardiac com-
plications, including decompensated heart failure,
arrhythmia, sequelae of coronary artery disease, angina
pectoris, or acute myocardial infarction, while mortality
was defined as any death after the surgery. The mortality
data were obtained from the Health and Welfare Data
Science Center, Ministry of Health and Welfare
(HWDC, MOHW), who hold a set of healthcare-related
databases that provide information from over 30 depart-
ments and ministries, including the National Health In-
surance Research Database (NHIRD). The NHIRD is an
administrative dataset derived from Taiwan’s universal
National Health Insurance program and contains re-
cords of the enrolled 99% of the Taiwanese population.
Statistical analysis
All variables were tested for normality using the
Kolmogorov-Smirnov test. Student’s t test was utilized
for normally distributed continuous variables, and the
Mann-Whitney U test was used for nonparametric data.
Fisher’s exact test or the chi-squared test was used for
categorical variables. Comparison was performed before
and after applying propensity score-matching.
Propensity score-matched analysis uses a propensity
score calculated from covariate data to match patients
from different study groups. The technique is often
applied to eliminate selection bias in orthopedic ob-
servational studies [10]. We employed this technique
(1:3 ratio of DTS group to control group) with a lo-
gistic regression model to adjust the covariates, in-
cluding basic demographic data (age, gender, BMI,
and ASA grade), preoperative comorbidities (all car-
diac comorbidities, CVA, diabetes, COPD, rheumatoid
disease, liver disease, renal disease, and cancer his-
tory), surgical variables (anesthesia type, use of a
cemented or cementless stem, duration of surgery,
and transfusion), and time interval from hospital ad-
mission to surgery, in order to decrease the differ-
ences in baseline conditions between groups and to
minimize selection bias in the performance of DTS.
Univariate and multivariate logistic regression analyses
were also conducted to determine whether DTS was
an independent factor affecting the rates of 90-day
cardiac complications and 1-year mortality after
adjusting for the confounding factors listed above.
Odds ratios (ORs) with 95% confidence intervals (CIs)
were calculated, and a p value of less than 0.05 was
taken to indicate statistical significance. All statistical
analyses were performed using Statistical Package for
Social Science (SPSS) version 22 software (SPSS Inc.,
IBM, Armonk, NY, USA) and NCSS Statistical Ana-
lysis and Graphics software (NCSS, LLC, Kaysville,
UT, USA).
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Results
There were several baseline differences between the pa-
tients who underwent preoperative DTS and those who
did not before propensity score-matching. The patients
who underwent DTS were of an older age (p < 0.001)
and a higher ASA grade (p < 0.001), and higher propor-
tions of those patients had ischemic heart disease (22.1%
vs 7.7%, p = 0.001), valvular heart disease (9.7% vs 2.5%,
p = 0.001), and diabetes mellitus (38.9% vs 29.5%, p =
0.044). In addition, cemented hemiarthroplasty was
more common in these patients (57.5% vs. 40.6%, p <
0.001). Furthermore, patients who underwent DTS had
an average wait of 4.6 days longer to receive surgery (7.0
± 12.4 days vs. 2.4 ± 3.3 days, p < 0.001).
After performing propensity score-matching, patients
who underwent DTS had a higher ASA grade (p = 0.01),
and a higher proportion of those patients had ischemic
heart disease (p = 0.038). Further standardized difference
analysis of ASA grade showed a reduction from 62.8% to
32.1%, while the standardized difference of ischemic
heart disease was reduced from 36.0 to 18.0%. All other
covariates and comorbidities were statistically balanced
after each examination of the Student t test and chi-
square test results. Patients who underwent DTS still
had a longer preoperative delay until surgery (7.0 ± 12.4
days vs. 3.7 ± 4.2 days, p < 0.001).
In our study, the 90-day cardiac complications ob-
served were as follows: 2 patients (0.2%) with angina
Table 1 Baseline demographic data, surgical factors, and length of stay in unmatched and matched patients who did and did not
undergo a dipyridamole-thallium scan
Non-thallium scan group
Thallium scan group (n = 113) Unmatched cohort (n = 731) p value Matched cohort (n = 339) p value
Age, mean ± SD, years 79.8 ± 8.3 74.7 ± 11.3 < 0.001 79.9 ± 8.3 0.901
Sex, n (%) 0.590 0.908
Male 37 (32.7) 221 (30.2) 109 (32.2)
Female 76 (67.3) 510 (69.8) 230 (67.8)
Body mass index, mean ± SD, kg/m2 22.6 ± 3.5 22.7 ± 4.1 0.774 22.5 ± 3.9 0.980
ASA grade, n (%) < 0.001 0.010
1 0 (0.0) 11 (1.5) 2 (0.6)
2 5 (4.4) 185 (25.3) 57 (16.8)
3 106 (93.8) 523 (71.5) 270 (79.6)
4 1 (0.9) 10 (1.4) 8 (2.4)
Delay until surgery, mean ± SD, days 7.0 ± 12.4 2.4 ± 3.3 < 0.001 3.7 ± 4.2 < 0.001
Delay until surgery > 2 days, n (%) 110 (97.3) 352 (48.2) < 0.001 127 (37.5) < 0.001
Preoperative comorbidities, n (%)
Ischemic heart disease 25 (22.1) 56 (7.7) < 0.001 47 (13.9) 0.038
CHF 6 (5.3) 27 (3.7) 0.431 20 (5.9) 0.816
Valvular heart disease 11 (9.7) 18 (2.5) 0.001 17 (5.0) 0.071
CVA 11 (9.7) 76 (10.4) 0.829 34 (10.0) 0.928
Diabetes 44 (38.9) 216 (29.5) 0.044 123 (36.3) 0.613
COPD 13 (11.5) 53 (7.3) 0.117 31 (9.1) 0.464
RA 1 (0.9) 14 (1.9) 0.440 3 (0.9) 1.000
Liver disease 2 (1.8) 37 (5.1) 0.121 7 (2.1) 1.000
Renal disease 14 (12.4) 59 (8.1) 0.129 37 (10.9) 0.668
Cancer 4 (3.5) 48 (6.6) 0.213 12 (3.5) 1.000
Anesthesia type, n (%) 0.071 0.597
General 94 (83.2) 651 (89.1) 289 (85.3)
Regional 19 (16.8) 80 (10.9) 50 (14.7)
Cemented stem, n (%) 65 (57.5) 297 (40.6) < 0.001 199 (58.7) 0.826
Time in surgical theater, mean ± SD, min 125.9 ± 36.3 132.3 ± 44.5 0.142 125.5 ± 33.8 0.930
ASA American Society of Anesthesiologists, CHF congestive heart failure, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, RA
rheumatoid arthritis, SD standard deviation
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pectoris; 32 (3.7%) with symptomatic heart failure; 60
(7.1%) with cardiac arrhythmia, including 53 with atrial
fibrillation with rapid ventricular response, 5 with right
bundle branch block, and 2 with episodic paroxysmal
supraventricular tachycardia (asymptomatic sinus brady-
cardia or tachycardia; first-degree atrioventricular block
was excluded); 1 (0.1%) with a history of thoracic aortic
dissection; and 6 (0.7%) with acute myocardial infarction.
After propensity score-matching, the incidence of 90-
day cardiac complications was 19.5% in the DTS group
and 15.6% in the control group (p = 0.343).
The 90-day mortality (0.9% vs. 1.2%, p = 0.795) and 1-
year mortality rates (10.6% vs 13.3%, p = 0.462) were
similar between the two groups (Fig. 1). Furthermore,
we regarded the 23 patients with positive DTS findings
as a subgroup and compared this group with the
remaining 90 patients with negative DTS findings and
the 339 patients in the control group. The 1-year mor-
tality rate was still not significantly different between the
three subgroups according to the results of the chi-
square test (p = 0.706).
The correlations of DTS with the rates of 90-day car-
diac complications, 90-day mortality, and 1-year mortal-
ity are depicted in Table 2. Multivariate analysis revealed
no significant associations of DTS with the rates of 90-
day cardiac complications (adjusted OR [aOR] = 1.44;
95% CI 0.71 to 2.91, p = 0.309), 90-day mortality (aOR =
9.80; 95% CI 0.23 to 424.80, p = 0.235), or 1-year mortal-
ity (aOR = 0.54 95% CI 0.24 to 1.20, p = 0.128). Analysis
of the propensity score-matched cohort also confirmed
no significant differences in terms of the correlations of
DTS with the rates of 90-day cardiac complications
(aOR = 1.32; 95% CI 0.75 to 2.33, p = 0.332), 90-day
mortality (aOR = 0.75; 95% CI 0.08 to 6.71, p = 0.797),
or 1-year mortality (aOR = 0.622, 95% CI 0.27 to 1.42, p
= 0.259). We performed further subgroup evaluation of
cardiac complications in order to assess the correlations
of DTS with postoperative unstable angina and acute
myocardial infarction, and no statistically significant dif-
ferences between the DTS group and the non-DTS
group were observed (p = 0.437 and 0.272, respectively).
Independent risk factors for postoperative 90-day car-
diac complications included an ASA grade ≥ 3 (OR 3.19,
95% CI 1.44 to 7.08, p = 0.004) and pre-existing cardiac
comorbidity (OR 5.56, 95% CI 3.35 to 9.25, p < 0.001) in
the multivariate analysis (Table 3). Independent risk fac-
tors for 1-year mortality were a long delay until surgery
(OR 1.15, 95% CI 1.06 to 1.25, p = 0.001), an older age
(OR 1.05, 95% CI 1.00 to 1.10, p = 0.040), a low BMI
(OR 0.89, 95% CI 0.81 to 0.98, p = 0.015), and the pres-
ence of renal disease (OR 4.43, 95% CI 1.71 to 11.46, p =
0.002) in the multivariate analysis (Table 4).
Of the 113 patients who underwent DTS, 90 (79.7%)
had negative findings and 23 (20.3%) were found to have
reversible myocardial ischemia. According to the follow-
up records of these 23 patients, 10 (8.8%) underwent
cardiac catheterization, but only 3 (2.7%) underwent a
primary coronary intervention (PCI) with stenting, using
either bare-metal or drug-eluting stents, or balloon
angioplasty; the 7 patients (6.2%) who did not undergo a
PCI during cardiac catheterization were treated in ac-
cordance with the judgment of a cardiologist. All of the
10 patients who underwent cardiac catheterization or
further PCI received surgery eventually, and none of
these 10 patients had postoperative cardiac complica-
tions or died within 90 days. Of the 13 patients (11.5%)
who underwent DTS and who did not undergo cardiac
catheterization, one developed postoperative myocardial
infarction, but soon recovered after PCI with stenting;
the follow-up records of this patient for 1 postoperative
year were examined, and no further cardiac morbidity or
mortality was documented (Fig. 2).
All of the 23 patients in the DTS group with reversible
myocardial ischemia were alive at 90 days postoperatively.
Three patients (13%) who did not receive a cardiac
catheterization were dead within 1 year after surgery. One
of those patients had probable reversible myocardial ische-
mia, and the leading cause of death was respiratory failure
after a benzodiazepine overdose. The second patient had
three-vessel coronary artery disease, atrial fibrillation and
a history of decompensated heart failure post-mechanical
ventilation 1 year prior to surgery, and the leading cause
of death was decompensated heart failure. There was no
evidence of new onset of myocardial ischemia in the sec-
ond patient according to the documented levels of cardiac
enzymes and the results of electrocardiography. The final
patient had an equivocal result in the thallium test, and
the leading cause of death was pneumonia. In no case of
mortality was there significant evidence of a relationship
with myocardial ischemia.
Fig. 1 Rates of 90-day cardiac complications, 90-day mortality, and
1-year mortality in patients who did and did not undergo a
dipyridamole-thallium scan after propensity score-matching
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Discussion
The results of our study suggested that the rate of 90-
day cardiac complications was still high despite the use
of DTS (19.5% vs. 15.6%, Fig. 1). Utilization of preopera-
tive DTS was not significantly associated with a change
in the rate of 90-day overall cardiac complications (OR
= 1.32; 95% CI 0.75 to 2.33; p = 0.332, Table 2) after
controlling the confounders. Further subgroup evalu-
ation of patients with postoperative unstable angina and
acute myocardial infarction was performed, which also
showed no statistically significant differences between
the two groups (p = 0.437 and 0.272, respectively). We
found that patients with an ASA grade ≥ 3 and those
with pre-existing cardiac comorbidities (ischemic heart
disease, congestive heart failure, and valvular heart dis-
ease) were associated with an increased risk of 90-day
cardiac complications. Furthermore, among the patients
who underwent DTS, only one (4.3%) had myocardial in-
farction after surgery, and no mortality was observed
within 90 days postoperatively. We examined the records
of the 23 patients with positive DTS findings for up to 1
year post-surgery; of these 23 patients, 3 who did not
undergo cardiac catheterization were dead, but the lead-
ing causes were not directly related to myocardial ische-
mia. Our results demonstrated that the performance of
DTS was not associated with a reduction in the rate of
cardiac complications.
DTS was not found to be associated with a change in
the 90-day mortality rate (aOR = 0.75; 95% CI 0.08 to
6.71; p = 0.797) or the 1-year mortality rate (aOR = 0.62,
95% CI 0.27 to 1.42; p = 0.259) (Table 2) after control-
ling the confounders in this study. We assumed that
DTS may lead to fewer cardiac complications and alter
the mortality rate in light of potential improvement in
the selection of the most suitable coronary interventions
after DTS. However, the mortality rate in the patients
with positive DTS findings was not statistically signifi-
cantly different to that in the patients with negative DTS
findings or the control group (p = 0.706). The benefit of
DTS was not as strong as has been demonstrated in
studies examining other specialties, such as thyroid and
cardiovascular surgery [8, 9].
A delay in performing surgery by 48 h was not an in-
dependent factor related to the rate of 90-day complica-
tions according to the results of multivariate logistic
regression (OR1.50, 95% CI 0.76 to 2.95, p = 0.243);
however, it was significantly related to the rate of 90-day
cardiac complications according to Pearson chi-square
analysis (p = 0.035). These results may imply that de-
layed surgery did not affect patient outcomes directly
but was a reflection of the comorbidities that contrib-
uted to postoperative complications. Thus, in patients
with cardiac comorbidities or an ASA score of 3 or 4,
surgery could have been delayed in order to allow im-
provement in the general condition of the patient. It is
difficult to set precise cut-off points to define early and
Table 2 Univariate and multivariate logistic regression models evaluating the associations of dipyridamole-thallium scan with the
rates of 90-day cardiac complications, 90-day mortality, and 1-year mortality
Outcome Unmatched cohort Matched cohort
Unadjusted OR (95% CI) p value Adjusted ORa (95% CI) p value Adjusted ORb (95% CI) p value
Overall 90-day cardiac complications 1.86 (1.11–3.13) 0.019 1.44 (0.71–2.91) 0.309 1.32 (0.75–2.33) 0.332
Unstable angina 6.52 (0.41–104) 0.186 4.26 (0.12–154) 0.429 3.02 (0.19–48.1) 0.437
Acute myocardial infarction 3.28 (0.59–18.1) 0.174 2.83 (0.38–21.2) 0.310 3.04 (0.42–21.3) 0.272
90-day mortality 0.92 (0.11–7.58) 0.941 9.80 (0.23–424.8) 0.235 0.75 (0.08–6.71) 0.797
1-year mortality 1.09 (0.57–2.08) 0.799 0.54 (0.24–1.20) 0.128 0.62 (0.27–1.42) 0.259
aAdjusted for age, sex, body mass index, American Society of Anesthesiologists (ASA) grade, preoperative comorbidities (ischemic heart disease, congestive heart
failure, valvular heart disease, cerebrovascular accident, diabetes, chronic obstructive pulmonary disease, rheumatoid arthritis, liver disease, renal disease, and
cancer history), surgical variables (anesthesia and cemented stem, operative duration, and transfusion), and duration to surgery
bAdjusted for ASA grade and ischemic heart disease
OR odds ratio, CI confidence interval






OR 95% CI p value
ASA grade ≥ 3 1.16 0.41 3.19 1.44 to 7.08 0.004
Cardiac comorbidities 1.72 0.26 5.56 3.35 to 9.25 < 0.001
Cardiac comorbidities included ischemic heart disease, congestive heart
failure, and valvular heart disease
OR odds ratio, CI confidence interval, ASA American Society
of Anesthesiologists






OR 95% CI p value
Delay until
surgery, days
0.14 0.42 1.15 1.06 to 1.25 0.001
Age, years 0.05 0.02 1.05 1.00 to 1.10 0.040
Body mass
index, kg/m2
-0.11 0.05 0.89 0.81 to 0.98 0.015
Renal disease 1.49 0.49 4.43 1.71 to 11.46 0.002
OR odds ratio, CI confidence interval
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Fig. 2 Flowchart showing the selection process of patients and the further decision-making in the two groups, categorized according to
performance of a dipyridamole-thallium scan
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delayed surgery, but generally, the optimal timing might
be considered between 12 and 48 h after presentation at
the hospital based on current evidence [11].
It is worth mentioning that a long delay until surgery
(OR 1.15, 95% CI 1.06 to 1.25, p = 0.001) was associated
with the 1-year mortality rate in our study. Several previ-
ous studies found that a prolonged duration until sur-
gery (≥ 48 h) for hip fractures may increase the 30-day
and 1-year mortality rates [12, 13]. However, it is a fre-
quent practice that preoperative consultation with an-
other service is obtained for risk stratification and
medical optimization. While the goal is to make a deci-
sion to proceed immediately or medically optimize the
patient first, the process of preoperative medical evalu-
ation usually takes 1 to 2 days before the patient can be
taken to surgery [14]. Among the common preoperative
examinations, DTS may take longer to organize, as it is
often dependent on scanner availability and time of day
[15–18], and an average delay of 4 days was observed at
our institution.
Being overweight is generally considered a risk factor
related to high morbidity and mortality, but the results
of recent studies suggested that obese patients may have
had a lower mortality rate after hip fracture in old pa-
tients with comorbidities. This phenomenon is termed
the “obesity paradox” in the literature [19], but there is
debate over the evidence and physiology. Hedstrom
et al. [20] assumed that there exists a prolonged cata-
bolic response after stress suffered following a hip frac-
ture, and patients with a higher BMI may have a greater
metabolic reserve to enable them to better endure this
stress, which was also found to be the case in critical ill-
ness [21]. The results of our study suggested a higher 1-
year mortality rate in patients of low BMI, which was
compatible with previous literature (OR 0.89, 95% CI
0.81 to 0.98, p = 0.015), and this indicates the import-
ance of nutritional support, especially in patients with
cachexia.
The incidence of hip fracture is high among patients
with renal failure due to osteoporosis and osteodystro-
phy, and there is evidence to suggest that patients with
chronic kidney disease (CKD) have a higher mortality rate
after hip fracture in the elderly [22]. Postoperative care of
CKD patients is always challenging due to difficulty in fluid
management, higher comorbidity, and catastrophic compli-
cations after acute exacerbation of renal failure. Our re-
search indicated a higher 1-year mortality rate in patients
with renal disease (OR 4.43, 95% CI 1.71 to 11.46, p =
0.002), and a multi-discipline protocol should be estab-
lished in the future, as these patients may not participate in
standard rehabilitation and osteoporosis treatment.
Ricci et al. [23] demonstrated that preoperative cardiac
testing (DTS, echocardiography, and cardiac catheterization)
did not change the management of perioperative orthopedic
surgery or medical therapy in elderly patients with hip frac-
tures but did incur a huge cost of over $47 million annually
in the USA; patients undergoing cardiac testing had a delay
to surgery on average 3.3 days, which was 1.4 days greater
than those who did not. Multiple studies have also demon-
strated that preoperative cardiac testing with echocardiog-
raphy delays surgery without a significant change in
preoperative cardiac medications or anesthesia [14, 24–26].
In addition, the cost of a thallium test is 261.22 dollars at our
institution. Compared with previous studies, we included
more patients in our study; moreover, we performed propen-
sity score analysis to control possible group differences in pa-
tients’ background conditions and reduce the effect of
selection bias. We also analyzed the independent factors re-
lated to postoperative cardiac complications and the 1-year
mortality rate. It is worth mentioning that we extracted mor-
tality data from the records of the Health and Welfare Data
Science Center, which included over 30 medical institutions
and over 99% of the population of Taiwan. Accordingly, our
mortality data were reliable, and this strengthened the power
of the analysis.
It is rational to consider that perioperative cardiac as-
sessment could lead to safer surgery and fewer cardiac
complications. However, the results of previous studies
did not indicate increased benefit in cases of geriatric
hip trauma. Thus, we suppose that over-screening may
occur in daily practice. Currently, during preoperative
assessment by a cardiologist following the ACC/AHA
guidelines, patients who have a functional capacity of < 4
MET require further evaluation, which is arbitrary and
subjective and may lead to over-diagnosis and incorrect
indications of cardiac examinations. Vigoda et al. [27]
performed a study of 548 anesthesiologist residents na-
tionwide and examined their judgment in different sce-
narios. Fewer than half of the participants adhered to
correct practice in accordance with standard care as set
down in the 2007 ACC/AHA guidelines. We also as-
sumed that the evolving minimally invasive technique of
hemiarthroplasty with a reduced surgical duration, in
conjunction with postoperative early rehabilitation with
mechanical/pharmaceutic thromboembolism prophy-
laxis, would result in a lower incidence of postoperative
morbidity as compared with the same surgery decades
ago. There may exist an imbalance between performance
of an expensive nuclear imaging test, which delays sur-
gery for up to 4 days, and its clinical benefit.
Highly selective coronary angiography and interven-
tions are no doubt helpful in terms of decreasing post-
operative morbidity/mortality. In our study, 113 patients
underwent DTS, but only 10 received coronary angiog-
raphy, and only 3 of those 10 patients required interven-
tions with a stenting procedure (2.7%). Thus, we
identified a low rate of selective angiography with PCI
after obtaining the results of DTS, which may account
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for a decreased clinical benefit of testing. The thallium
scan has a questionable negative predictive value in pa-
tients with “balanced ischemia” due to global myocardial
ischemia leading to poor interpretation of a relative per-
fusion defect in affected segments, which is a common
phenomenon in nuclear imaging [28–30].
It is necessary to develop a better cardiac assessment
tool with greater specificity that is less time-consuming
to perform and has a better negative predictive value.
Focused transthoracic echocardiography, or goal-
directed focused cardiac ultrasound (FoCUS), has gar-
nered interest for its use in perioperative assessment
under specific conditions, especially for urgent surgery,
due to its availability, portability, and time-saving prop-
erty [31, 32]. Canty et al. [33] performed a prospective
observational study of 99 patients who had suspected
cardiac disease or were older than 65 years, in which
preoperative focused echocardiography was performed
by an anesthesiologist. In that study, this examination
allowed identification of 64% of patients with cardiac
disease, and clinical measures including referral to a car-
diologist, change to the type of surgery performed, or in-
traoperative optimization were implemented in 36% of
patients. However, there has been no comparative study
of formal stress echocardiography and bedside FoCUS,
and there remains uncertainty around the appropriate
level of experience required in order to decrease the
number of false negatives. Currently, there is no consen-
sus with regard to a thallium scan substitute, but com-
puted tomographic angiography (coronary CTA) has
been noted to be useful. Huang et al. [34] investigated
the value of coronary CTA in non-cardiac surgeries and
found that this examination yielded improved periopera-
tive risk stratification with a low rate of major cardiac
events, high specificity, and good negative predictive
value. The risk of a major cardiac event was reported to
be 14% in patients with significant CTA findings [34].
Future research involving prospective, randomized allo-
cation of patients is warranted to minimize selection bias
and group differences.
There were several limitations of this study that should
be considered. Most notably, there may have been selec-
tion bias, as DTS was performed in high-risk patients
who were likely inherently subject to a higher risk of 90-
day cardiac complications. We attempted to balance the
baseline patient condition and control for potential con-
founders, but the DTS group still had a higher ASA
grade, higher rates of ischemic heart disease and delayed
surgery, even further standardized difference analysis
showed reduction of imbalance between groups. Second,
the decision to utilize DTS was made by different cardi-
ologists, and thus there may be some variation in patient
stratification and the cardiologists’ willingness to order
additional cardiac tests. Third, we focused on the rates
of 90-day cardiac morbidity and 1-year mortality and
thus did not account for any complications that may
have occurred beyond that follow-up duration.
Conclusion
Preoperative DTS was not associated with reductions in
the rates of 90-day cardiac complications and 1-year
mortality in patients with a femoral neck fracture under-
going cemented or cementless hemiarthroplasty. The pa-
tients in whom DTS was performed underwent surgery
4 days later on average than the patients who did not,
with no significant clinical benefit in terms of the rates
of 90-day cardiac complications and 1-year mortality.
Given the results of this study and those reported in
existing literature, we propose that routine DTS in pa-
tients with an isolated femoral neck fracture should not
be performed. We instead suggest that it is important to
consider the patient’s preoperative cardiovascular co-
morbidity, underlying disease, and functional status dur-
ing the preoperative assessment.
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